SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on August 16, 2022. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report primarily addresses a Regulation FD disclosure regarding the growth of the company's sales pipeline.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain audited financial statements or quarterly results.
Material Changes
The material change disclosed is the announcement of growth in the company's sales pipeline, as detailed in the press release attached as Exhibit 99.1. No quantitative comparison to prior periods is provided in the text of this filing.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of sales pipeline growth. The filing explicitly states that the Company undertakes no obligation to update, supplement, or amend the materials attached. The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release, August 16, 2022) for specific details on the sales pipeline growth.
- Verify the trading status of BSGM on the NASDAQ Capital Market.
- Consult the most recent 10-Q or 10-K filings for actual financial performance metrics, as this 8-K does not contain them.
- Note the disclaimer that the Company is not obligated to update the pipeline information provided.